MiR-21 and BNP are highly expressed in patients with preeclampsia complicated with heart failure and are expected to be important biomarkers for diagnosing preeclampsia complicated with heart failure and assessing the degree of heart failure in these patients, as reported by Kan’s study [13]. The gene discussed is NPPB; the disease is preeclampsia.